The global biomarkers market is valued $24.10 Billion in 2015. The market is expected to reach $45.55 Billion by 2020 at a CAGR of 13.58% from 2015 to 2020. Biomarkers are characteristic biomolecules in the human body. The normal physiological levels of biomarkers change in diseased states or on the administration of medication. They are classified on the basis of their application in different medical processes.
Complete report of Biomarkers Market spread across 178 Pages, Profiling 12 Companies and Supported with 93 Tables and 102 Figures is now available at http://www.reportsnreports.com/reports/145494-biomarkers-market-discovery-technologies-applications-indications-global-trends-opportunities-forecasts-2013-2018.html .
This report segments the global biomarkers market on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, and software. The market, on the basis of type, includes safety biomarkers, efficacy biomarkers, and validation biomarkers. With rapid innovations in biomarker testing techniques, researchers are now able to test biomarkers very easily. Rapid developments in the field of biomarkers have considerably enhanced the accuracy and efficiency of biomarker testing.
Biomarkers Market, By Application
2 Diagnostics Development
3 Drug Discovery and Development
4 Personalized Medicine
5 Disease Risk Assessment
The application segments included in biomarkers market report are diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other applications. The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The report maps each test type and product segment in 11 geographic and regional segments.
Sample Copy of this Research is Available Now
The geographic analysis reveals that North America will account for the largest share of the global biomarkers market in 2015. Growth in this market can be attributed to strong growth trends in pharmaceutical companies and CROs. The Asian regional segment is expected to register double-digit growth from 2015 to 2020 owing to the expansion of leading biomarker companies and increased R&D spending. R&D spending in Asia increased from $177 billion in 2003 to $329 billion in 2010, at a CAGR of 9.29%. The R&D spending in Asia accounted for 27.13% of the global R&D expenditure in 2010.
Major players in biomarkers market include QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Enzo Biochem (U.S.), EKF Diagnostics Holdings plc (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Click now for more Details, Quiries and Discount and Other Information on this study “Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020” research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=145494 .
This report segments the global market by product, type of biomarker, application, disease indication, and geography. The product segments included in this report are consumables, services, & software. Based on type, biomarkers are segmented into safety, efficacy, and validation biomarkers.
The applications included in biomarkers market report are diagnostics development, drug discovery & development, personalized medicine, disease risk assessment and other applications. The disease indication segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.
On related note another research titled "Biomarkers Market” is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers is available at http://www.reportsnreports.com/reports/420487-cancer-biomarkers-market-by-tumor-breast-lung-prostate-type-protein-genetic-biomarkers-profiling-technology-proteomics-genomics-imaging-immunoassay-application-diagnostic-drug-discovery-prognostic-geography-global-forecast-to-2020.html
Explore more reports on Biotechnology at http://www.reportsnreports.com/market-research/biotechnology/
ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013